INNV
InnovAgeBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
The post-earnings bull read is that Q3 showed another step-up in execution: revenue grew 15.5%, Adjusted EBITDA nearly tripled year over year to $30.5 million, guidance was raised again, and cash generation improved. The immediate earnings reaction was positive, with after-hours coverage pointing to investors focusing on the beat/raise rather than the GAAP loss.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +0.2.
What can break
Growth still depends on filling existing centers, maturing newer Florida locations, and maintaining lower cost per participant; if utilization, pharmacy, or staffing trends reverse, recent margin gains could fade [#8-K-2026-05-05].
Momentum
97
Value
52
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.25 · Bull $9.25 · Bear $5.75
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $7.00
Why
Momentum97 · Δ7d +0.2
Value52 · Δ7d -0.1
Sentiment34 · Δ7d -1.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
97
26% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+2.3
Value
52
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.5
Sentiment
34
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-5.6
Why this grade
Composite grade B. Momentum 97.1 / Value 51.6 / Sentiment 33.5
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.5B
Beta
0.56
Shares Out
135.74M
P/E (TTM) · Derived
-50.4
P/S (TTM)
0.84
P/FCF (TTM)
20.61
Rev YoY
+15.5%
EPS YoY
+157.8%
Gross Margin
+19.8%
Op Margin
-1.9%
Net Debt
-$4.83M
Current Ratio
1.03
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology